Supplementary figures and tables: Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis.docx

Supplementary Figure 1. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Risk of Bias Assessment Results by Outcome for Studies Included in Base-case Analysis Using Risk of Bias in Non-randomized Studies of Interventions’ Supplementary Figure 2. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Risk of Bias Assessment Results by Domain for Studies Included in Base-case Analysis Using Risk of Bias in Non-randomized Studies of Interventions’ Supplementary Figure 3. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Network Meta-analysis Results for Ischemic Stroke’ Supplementary Figure 4. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Network Meta-analysis Results for Intracranial Hemorrhage’ Supplementary Figure 5. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Network Meta-analysis Results for Gastrointestinal Bleeding’ Supplementary Figure 6. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Network Meta-analysis Results for All-cause Mortality’ Supplementary Table 1. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Search Strategy’ Supplementary Table 2. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Population, Interventions and Comparisons, Outcomes, Study Design, and Time Period Selection Criteria’ Supplementary Table 3. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Process for Selecting Data among Kin Publications’ Supplementary Table 4. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Key Characteristics from Studies Included in the Network Meta-analysis’ Supplementary Table 5. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘Outcomes from Studies Included in the Network Meta-analysis’ PRISMA checklist. Real-world Evidence Comparing Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Systematic Review and Network Meta-analysis ‘PRISMA 2020 Checklist’